Evidence map›Paper›PMID 29143800›Full record

ReviewInternational journal of molecular sciences2017

Hungry Neurons: Metabolic Insights on Seizure Dynamics.

Paolo Bazzigaluppi, Azin Ebrahim Amini, Iliya Weisspapir, Bojana Stefanovic, Peter L Carlen

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mitochondrial Glutamine Metabolism Drives Epileptogenesis in Primary Hippocampal Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  10. Article
  11. Hyperpolarized [1-Brain communications · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. In Vivo Neocortical [K]o Modulation by Targeted Stimulation of Astrocytes.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Paolo BazzigaluppiKrembil Research Institute, Fundamental Neurobiology, Toronto, ON M5T 2S8, Canada. Paolo.Bazzigaluppi@uhnresearch.ca.ORCID 0000-0002-0434-2548
Azin Ebrahim AminiKrembil Research Institute, Fundamental Neurobiology, Toronto, ON M5T 2S8, Canada. azin.amini@mail.utoronto.ca.
Iliya WeisspapirKrembil Research Institute, Fundamental Neurobiology, Toronto, ON M5T 2S8, Canada. i.weisspapir@gmail.com.
Bojana StefanovicSunnybrook Research Institute, Medical Biophysics, Toronto, ON M4N 3M5, Canada. bojana@sri.utoronto.ca.
Peter L CarlenKrembil Research Institute, Fundamental Neurobiology, Toronto, ON M5T 2S8, Canada. carlen@uhnresearch.ca.ORCID 0000-0002-3339-8102
Sunnybrook Health Science Centre · CAUniversity of Toronto · CAKrembil Foundation · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy afflicts up to 1.6% of the population and the mechanisms underlying the appearance of seizures are still not understood. In past years, many efforts have been spent trying to understand the mechanisms underlying the excessive and synchronous firing of neurons. Traditionally, attention was pointed towards synaptic (dys)function and extracellular ionic species (dys)regulation. Recently, novel clinical and preclinical studies explored the role of brain metabolism (i.e., glucose utilization) of seizures pathophysiology revealing (in most cases) reduced metabolism in the inter-ictal period and increased metabolism in the seconds preceding and during the appearance of seizures. In the present review, we summarize the clinical and preclinical observations showing metabolic dysregulation during epileptogenesis, seizure initiation, and termination, and in the inter-ictal period. Recent preclinical studies have shown that 2-Deoxyglucose (2-DG, a glycolysis blocker) is a novel therapeutic approach to reduce seizures. Furthermore, we present initial evidence for the effectiveness of 2-DG in arresting 4-Aminopyridine induced neocortical seizures in vivo in the mouse.

Indexed as

Energy MetabolismAnimalsDisease Models, AnimalHumansNeuronsSeizures2 deoxyglucosebeta hydroxybutyrateepilepsymetabolismseizures

Identifiers

PMID29143800
PMCPMC5713239
OpenAlexW2765809544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.